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INTRODUCTION 
ANTIBACTERIAL AGENTS1-5 
 Drugs used for treating infectious disease are called antibiotics, 
anti-infectious agents, antimicrobial or chemotherapeutic agents. The first 
three-antibiotics, anti-infectious agents and antimicrobial drugs are 
generally used to describe the drug used for treating infectious disease, 
while the term chemotherapeutic drugs is more associated with drugs 
used for treating cancer. 
 Antibiotics are the compounds produced by microorganisms and 
that are able to kill or inhibit the growth of bacteria and other 
microorganisms. This definition makes a specific distinction between 
antimicrobial drugs produced by microorganisms and completely synthetic 
product. Today the word antibiotic is used quite often for specifying 
antimicrobial drugs in general. 
CLASSIFICATION 
1.  Beta-lactam antibiotics :  Penicillins, Cephalosporins,  
   Monabactams, Carbapenems 
2. Aminoglycosides : Streptomycin, Gentamicin 
3.  Macrolide antibiotics : Erythromycin, Roxithromycin 
4.  Glycopeptide antibiotis :  Vancomycin, Teicoplanin 
5.  Polypeptide antibiotics : Polymyxin-B, Bacitracin 
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6.  Lincomycins :  Clindamycin. 
7.  Tetracyclines : Oxytetracycline, Doxycycline. 
8. Nitrobenzene derivatives : Chloramphenicol 
9. Sulfonamide and related drugs: Sulfadiazine, Dapsone. 
10.  Diaminopyrimidines : Trimethoprim, Pyrimethamine 
11.  Quinolones : Nalidixic acid, Ciprofloxacin 
12.  Nitrofuran derivatives : Nitrofurantoin, Furazolidone 
ANTIFUNGAL AGENTS 
 Antifungal agents are the drugs used for superficial and systemic 
fungal infection. 
Classification 
 Antifungal agents are classified as follows  
1.  Antibiotics 
 (a) Polyenes :  Amphotericin-B, Nystatin 
 (b) Heterocyclic benzofuran : Griseofulvin 
2.  Antimetabolites :  Flucytosine 
3.  Azoles 
 (a) Imidazoles:   
 Topical  : Clotrimazole, Miconazole 
 Systemic  : Ketoconazole  
 (b) Triazoles :  Fluconazole 
4.  Allylamine :  Terbinafine 
5.  Other topical agents :  Benzoic acid, Tolnaftate 
6.  New antifungal agents : Echinocandins, Sordarin   
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   derivatives. 
 
BASIC MECHANISMS OF ANTIBIOTICS 
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CHALCONES 6 
 Chalcone is an aromatic ketone that forms the central core for a 
variety of important biological compounds. They show antibacterial, 
antifungal, antitumor, anti-inflammatory properties. Some chalcones 
demonstrated the ability to block voltage-dependent potassium channels. 
They are also intermediates for the biosynthesis of flavonoids, which are 
the substances widespread in the plants with an array of biological 
activities. Chalcones are the intermediates for the synthesis of pyrans7, 
pyrazolines8,9, 1,5-benzodiazepine10, 1,5-benzothiazepine11. 
 
NATURALLY ISOLATED CHALCONES: 
1)  Aurentiacin12:  
 Isolated from Pityrogramma triangularis var. pallida 
H3CO
CH3
OH
OCH3
O
Aurentiacin  
2)  Sophoradin13:  
 It is an isoprenyl chalcone isolated from a Chinese drug, Guang-
dou-gen or Shan-dou-gen, which is the root of Sophora subprostrata 
(Leguminosae). The isolated compound showed anti-ulcer effect on both 
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Shay’s pylorus-ligated rats and water immersed and restraint stress rats.  
 
OH
CH3
CH3
OH
O
CH3 CH3
OH
CH3
CH3
 
3)  2’,6’-dihydroxy-4’-methoxychalcone14 
 This compound was isolated from inflorescences of Piper aduncum 
belongs to the family Piperaceae which showed a significant in vitro 
activity against promastigotes and amastigotes of Leishmania 
amazonensis.   
O
H3CO
OH
OH
 
 
2’,6’-dihydroxy-4’-methoxychalcone 
4)  Licochalcone A15 
 It is an oxygenated chalcone isolated from the roots of Chinese 
licorice plant, which inhibited the growth of both Leishmania major and 
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Leishmania  donovani promastigotes and amastigotes. 
PYRANS16 
 In chemistry, a pyran is a six membered heterocyclic ring consisting 
of five carbon atom and one oxygen atom containing two double bonds. 
The molecular formula is C5H6O. There are two isomers of pyran that differ 
by the location of double bonds. In 2H-pyran, the saturated carbon is at 
position 2, whereas in 4H-pyran, the saturated carbon is at position 4. 
Although the pyran themselves have little significance in chemistry, a 
variety of their derivatives are important biological molecules. 4H-Pyran 
easily disproportionate to the corresponding dihydropyran and pyrylium 
ion, which is easily hydrolyzed in aqueous medium. 
    
O
       
O
 
         2H-pyran           4H-pyran 
 Six membered heterocyclic compounds containing oxygen atom 
such as 4H-pyran-4-one ( -pyrone) constitute an important class of 
biologically active natural and synthetic product. A large number of natural 
product containing -pyrone unit has been isolated which shows anti-HIV, 
anti-tumor, radical scavenging activity, antifungal, Inhibitor of bone 
resorption, antibacterial, cytotoxic activity. In the light of these results a 
number of aromatic and heteroaromatic derivatives of pyran with 
cabonitrile or carboethoxy group has been prepared and screened for their 
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possible antibacterial and antifungal activities. 
NATURAL PRODUCTS CONTAINING PYRAN MOIETY: 
1)  Phenoxan17:  
 It is a naturally occurring heterocyclic compound, isolated from a 
soil microorganism and discovered to have Anti-HIV activity. 
 
 
 
 
 
 2)  Allixin18,19: 
 It is one of the phytoalexins, first isolated from garlic,  
Allium sativum L. It has anti-tumor and radical scavenging effect.  
 
 
       
 
3)  9’-oxopodopyrone & 10’-oxopodopyrone20:  
 Isolated from leaves of Gonystylus keithii. This ү-pyrone markedly 
inhibited the bovine parathyroid hormone induced Ca release from 
neonatal mouse calvaria in vitro. It is the first time ү-pyrone showed 
inhibitory effects on bone resorption, and these compounds may be seed 
O
O
H3CO
CH3
OH
CH3
Allixin
O
CH3
O
CH3
OCH3
N
O
Ph
CH3
Phenoxan
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compound of new drug for osteoporosis. 
 
       
 
 
 
4)  Discodermolide21:  
 It is a marine natural product isolated from sponge Discodermia 
dissoluta, reported to inhibit the proliferation of T cells and exhibit 
immunosuppressive activity. 
OO
CH3
OH
CH3
CH2
CH3CH3CH3
OH O O
NH2
CH3
CH3
OH
CH3
OH
Discodermolide  
5)  Thyrsiferol22:  
 It is isolated from marine red algae of the genus Laurencia 
thyrsifera was found to have cytotoxic, anti-viral and anti-tumor activity. 
  
  
 O O
O
OH
O
H
H
H
H
H H
H H OH H
CH3
CH3
OH
H
Br
O
CH3
H3CO
O
R1
CH3
R2
R3
1
2
3
4
5
6
78
1'
9'
10'
9'-oxopdopyrone R1,R3= H, R2 = O
10'-oxopdopyrone R1,R2= H, R3=O
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MEDICINALLY USEFUL DRUGS WITH PYRAN MOIETY23: 
 
 
 
 
 
 
 
 
  
 
  
 
CH3
CH3
O
O
CH3
CH3 CH3
O
OOH
H
H
Simvastatin
CH3
CH3
O
O
CH3
CH3 H
O
OOH
H
H
Lovastatin
O
OCH3
(CH2)8
COOH
CH3
CH3
CH3
O
OH
OH
Mupirocin
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SCHIFF'S BASE24 
 A Schiff's base is a functional group that contains a carbon-nitrogen 
double bond in which the nitrogen atom connected to an aryl or alkyl group 
but not hydrogen. Schiff's base are of general formula R1R2C=N-R3, where 
R3, is an aryl or alkyl group that makes the Schiff's base a stable imine. A 
Schiff's base synthesized from an aromatic amine and a carbonyl 
compound by nucleophilic addition leads to form a hemiaminal, followed 
by a dehydration to generate an imine. Due to their diverse reactivity, 
imines are common substrates in a wide variety of transformations. 
 
R1 , R2 = H, alkyl, aryl
R3 = alkyl, aryl  
 
 However the equilibrium in this reaction usually lies in favour of the 
free carbonyl group and amine, so that azeotropic distillation or use of 
dehydrating agent such as molecular sieves are required to push the 
reaction in favor of imine formation. Addition reaction of carbonyl 
compound with primary amines give imines that are stable under inert 
atmosphere but In the presence of oxygen or water, such imines quite 
readily hydrolyze or oligomerize. However, with an aryl group or certain 
stabilizing alkyl substituents on nitrogen, the imine formed is stable to 
oxygen and water is called a Schiff's base.  
O
R1
R2
+ NH2 R3 N
R1
R2 R3
+ H2O
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LITERATURE REVIEW  
CHALCONES 
Chalcones with antimicrobial activity 
1)   Popat et al.,25 (2004) synthesized various chalcones of 1-aryl-3-m-
chlorophenyl-2-propene-1-one. The synthesized compounds were 
shown antibacterial activity against Escherichia coli, Proteus 
vulgaris, Bacillus megaterium, Staphylococcus aureus. The above 
compounds also showed antifungal activity against Aspergillus 
niger. 
 
 
2)  Patel et al.,26 (2003) synthesized 3-(2'-chloro-6'-bromoquinolin-3'-
yl)-1-aryl-2-propen-1-one derivatives. The synthesized compounds 
were shown antibacterial activity against Escherichia coli, Proteus 
vulgaris, Bacillus megaterium, Staphylococcus aureus and 
antifungal activity against Aspergillus niger. 
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N
Br
R
O
Cl
2
2a : R= C6H
2b : R= 2-Br-C
2c : R= 4-C
2d : R= 4-Cl-C 
3)  Fathalla et al.,27 (2005) synthesized 2-Thiouracil-5-sulphonic acid -
N-(4-(3-substituted-2-propen-1-oxo) phenyl) amide derivatives. The 
synthesized compounds were shown invitro antibacterial activity 
against Staphylococcus aureus, Bacillus subtilis and antifungal 
activity 
against 
Microsporium canis, Sporotrichum schenkii. 
 
 
 
 
 
 
N
H
NH
O
S
S
NH
O
O R
O
2a-c
2a : R = p-nitrophenyl
2b : R = p-chlorophenyl
2c : R = 3-indolyl
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4)  Dandia et al.,28 (1993) synthesized 2-aryl-3-(3-aryl-3-oxoprop-1-
enyl)indole derivatives. The synthesized compounds were shown 
antibacterial activity against Escherichia coli and antifungal activity 
against Rhizoctonia solani. 
N
H
Ar
O
X
Y
1
1a : Ar= C6H5
1b : Ar= C6H5, X= F , Y= CH
1c : Ar= C6H5
 
5)  Mostahar et al.,29 (2006) synthesized (E)-1-(2',4'-dihydroxyphenyl)-
3-(3''-hydroxy-4-methoxyphenyl)prop-2-en-1-one. The synthesized 
compound was shown antibacterial activity against Bacillus 
megaterium, Streptococcus-β-haemolyticus, Escherichia coli, and 
Klebsiella species and also found antifungal activity against 
Aspergillus niger, Aspergillus fumigatus. 
  
 
 
 
 
Chalcones with anti-inflammatory activity 
6)  Jadhav et al.,30 (2007) synthesized 2',4'-difluorinated chalcones. 
O
OHOH
OH
OCH3
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The synthesized compounds were shown anti-inflammatory activity. 
R = 4-OCH3, 3-Nitro, or 3,4,5-Trimethoxy
O
F
F
R
 
7)  Jin et al.,31 (2007) synthesized 2',4',6'-tris(methoxymethoxy) 
chalcone derivative. The synthesized compound has potent anti-
inflammatory activity via heme oxygenase dependent pathway. 
 
 
 
 
 
 
Chalcones having cytotoxic activity 
8)  Mostahar et al.,32 (2006) synthesized (E)-1-(2',4'-dihydroxyphenyl)-
3-(3''-hydroxy-4''-methoxyphenyl)prop-2-en-1-one. The synthesized 
compound was shown cytotoxic activity which is compared with 
standard Bleomycin and Gallic acid. 
OCH2OCH3
CH3OCH2O
OCH2OCH3
O
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O
OHOH
OH
OCH3
 
Chalcones having insecticidal activity 
9)  Mudaliar et al.,33 (1995) synthesized 1-(4'-hydroxyphenyl)   -3- (3''-
phenoxy) phenyl-2-propene-1-one. The synthesized compound was 
shown insecticidal activity on house fly adult. The efficacy of this 
compound was compared with standard insecticide, Fenvalerate. 
 
 
 
 
 
Chalcone with antioxidant activity 
10)  Kim et al.,34 (2008) synthesized a series of dihydroxylated chalcone 
derivatives with diverse substitution on phenyl ring B and the para-
substituents on phenyl ring A were prepared and their radical 
scavenging activities were evaluated by simple DPPH test. 
O
OH
OC6H5
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O
R
OH
HO
A B
R = H, CH3, OCH3, Cl  
Chalcone with antiparasitic activity: 
11)  Laliberte et al.,35 (1968) synthesized some new heterocyclic 
chalcone analogues. The synthesized compounds were shown 
antiparasitic activity. 
S
O
R
R = 2-Cl, 3-Cl, 4-Cl  
Chalcones with antimycobacterial activity 
12)  Yar et al.,36 (2007) synthesized 1-(4-hydroxy-3-methylphenyl)-3-
[(substituted)phenyl]-2-propen-1-ones. The synthesized compounds 
were shown antimycobacterial activity. 
 
 
 
 
 
R
O
CH3
OH
R = 4-methoxyphenyl 
R = 4-Chlorophenyl 
R = 4-Fluorophenyl
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CYANOPYRANS 
Cyanopyran with antimicrobial activity 
1)  Popat et al.,25 (2004) were synthesized 2-amino-3-cyano-4-(3''-
chlorophenyl)-6-(4-methoxyphenyl)-pyran. The synthesized 
compound was shown antibacterial activity against Escherichia coli, 
Proteus vulgaris, Bacillus megaterium, Staphylococcus aureus and 
antifungal activity against Aspergillus  niger.  
 
  
    
 
 
 
2)  Patel et al.,26 (2003) synthesized 2-amino-3-cyano-4-(2'-chloro-6'-
bromoquinolin-3'-yl)-)-6-(p-tolyl)-4H-pyran. The synthesized 
compound was shown antibacterial activity against Escherichia coli, 
Proteus vulgaris, Bacillus megaterium, Staphylococcus aureus and 
antifungal activity against Aspergillus  niger. 
 
O NH2
CN
Cl
H3CO
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N Cl
Br
O
NH2
NC
CH3 
3)  Kanjariya et al.,37 (2004) synthesized 6-(α- isopropyl-p-
chlorophenyl-acetamidophenyl)-4-aryl-2-amino-3-cyanopyran. 3(a-
d). All the compounds were shown antibacterial activity against 
Escherichia coli, Proteus vulgaris, Bacillus megaterium, 
Staphylococcus aureus and antifungal activity against Aspergillus 
niger. 
  
 
 
 
 
 
 
4)  Nakum et al.,38 (2002) synthesized 2-amino-3-cyano-4-(2'-chloro 
substituted quinolin-3'-yl/aryl)-5-methyl-7-phenylpyrazolo (5,6-d)-
4H-pyrans (1a-b). The Synthesized compounds were shown 
antimicrobial activity against Staphylococcus aureus, Pseudomonas 
aeruginosa, Bacillus subtilis, Bacillus pumilus and Candida 
albicans. 
Cl
CH3CH3
NH
O
O
NH2
CN
R
3a : R = C6H5
3b : R = 2-Cl-C6H4-
3d : R = 2,6-(Cl)2-C6H3-
3a-d
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5)  Ei-assiery et al.,39 (2004) synthesized 6-amino-1-(2,4-dinitrophenyl)-4-
(4-methoxyphenyl)-3-methyl-1,4- dihydropyrano 2,3-c]pyrazole-5-
carbonitrile (3) which showed antibacterial activity against 
Staphylococcus aureus, Bacillus cereus, Serratia marcescens, Proteus 
mirabilis and antifungal activity against Aspergillus fungytus. 
 
 
 
 
 
 
   
 
 
 
6) Mohareb et al.,40 (2008) synthesized 17-(2-hydroxy-3-cyanopyran-
O
N
N
CH3
NH2
CN
R
1a : R = 2-chloro-7-methyl-3-quinolinyl
1b : R = 2-chloro-6-methyl-3-quinolinyl
1c : R = 2-chloro-6-methoxy-3-quinolinyl
1a-c
O
N
N
NO2
O2N
CN
NH2
O
CH3
CH3
3
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O
CH3
CH3 O
CN
OH
O
H3CO
CH3
CN
NHCOCH3
4a
6-yl)androst-4-en-3-one (6b). The synthesized compound showed 
antibacterial activity against Bacillus cereus, Bacillus subtilis and 
antifungal activity against Candida albicans.    
 
 
 
 
 
 
7)  Fathy et al.,41 (2004) synthesized 2-acetylamino-7-methoxy-4-(p-
tolyl)-4H-naptho[2,1-b]pyrane-3-carbonitrile (4a). The synthesized 
compound was shown antibacterial activity against Staphylococcus 
aureus, Bacillus cereus, Bacillus subtilis, Serratia marcescens, 
Proteus mirabilis, and Escherichia coli. 
 
 
 
 
 
 
Cyanopyrans with anticancer activity 
8)  Hammam et al.,42 (2001) synthesized 2-Amino-4-aryl-8-arylmethylene-
Chapter 6          
Spectral Studies 
 29
6-ethyl-5,6,7,8-tetrahydropyrano[3,2-c]pyridine-  3- carbonitrile which 
showed anticancer activity. 
N
O
Et
NH2
CN
Ar
Ar
Ar = 4-Cl-C6H4, 4-Br-C6H4  
 
9)  Hammam et al.,43 (2005) synthesized 2-Amino-4-aryl-9-fluoro-4,5-
dihydrobenzo[b]pyrano[4,3-b]pyrane-3-carbonitrile. The synthesized 
compound was shown anticancer activity. 
 
 
 
 
 
 
 
 
 
Cyanopyrans with antimycobacterial activity 
10)  Popat et al.,25 (2004) synthesized 2-amino-3-cyano-4-(3''-
O
O
OCH3
OCH3
NH2
CN
F
Chapter 6          
Spectral Studies 
 30
chlorophenyl)-6-(4-methoxyphenyl)-pyran. The synthesized 
compound showed antimycobacterial activity. 
O NH2
CN
Cl
H3CO  
       
11) Kanjariya et al.,26 (2004) synthesized 6-(α- isopropyl-p-
chlorophenylacetamidophenyl)-4-aryl-2-amino-3-cyanopyrans 3(a-
d). All the compounds were shown antimycobacterial activity. 
 
 
 
 
 
 
 
CARBOETHOXY PYRANS 
Pyrans with Antibacterial Activity 
12)  Dandia et al.,28 (1993) synthesized 3-[6-amino-5-carboethoxy-2-(4-
Cl
CH3CH3
NH
O
O
NH2
CN
R
3a : R = C6H5
3b : R = 2-Cl-C6H4-
3d : R = 2,6-(Cl)2-C6H3-
3a-d
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fluorophenyl)-pyran-4-yl]-2-phenyl indole. The synthesized 
compound was shown antibacterial activity against Staphylococcus 
albus, Escherichia coli and antifungal activity against Rhizoctonia 
solani. 
  
 
 
 
 
 
 
13)  Fathalla et al.,27 (2005) synthesized 2-Thiouracil-5-sulphonic  
acid N-(4-(6-amino-5-carboethoxy-4-substituted pyrano)phenyl) 
amide derivatives. The synthesized compounds were shown 
antibacterial activity against Bacillus subtilis, Staphylococcus 
aureus.. 
N
H
O
NH2
F
COOC2H5
C6H5
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Pyran with HIV-1 and HIV-2 inhibitors 
14)  Chavda et al.,44 (2002) synthesized monomethylated dimeric 
benzopyrans. Among the synthesized compounds 3,3'-(2-
chlorobenzylidene)-bis-(6-methyl-4-hydroxy coumarin) (3d) showed 
activity against HIV1 and HIV 2. 
 
 
 
 
 
 
Pyran with antiinflammatory activity 
15)  Ghate et al.,45 (2005) synthesized 6-Acetyl-3, 7-dimethyl-2-(coumarin-
4'-yl)furo[3,2-g]chromen-5-one. The synthesized compounds were 
shown excellent anti-inflammatory activity by carageenan induced 
edema model in rats using phenylbutazone as standard. 
N
H
NH
O
S
S
NH
O
O
O
NH2
COOEt
R'
R' = p-nitro phenyl or 3-Indolyl
O O
OH OH
CH3
O O
CH3
Cl
3d
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Pyran with anifeedant activity 
16)   Reddy et al.,46 (1995) synthesized 2,8-disubstituted-2,3,7,8-
tetrahydro-4,6-dioxo-4H,6H-benzo[1,2-b;5,4-b']dipyran. The 
synthesized compound was shown antifeedant activity. 
O O
O O
R R
R = 4-Cl-C6H4  
 
Pyran with antiallergic activity 
17)  Shahrisa et al., 47 (2000) synthesized 6-(2-Furyl)-2-(tetrazol-5-
 yl)-4H-pyranone which showed antiallergic activity. 
O O
O
CH3
CH3
CH3
O
O
R
O
5a-b
5a = R= 6-CH3
5b = R= 7-CH3
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Pyran with antioxidant activity 
18) Shetgiri et al.,48 (2003) synthesized 4', 5, 7-trihydroxy-3'-
 methoxyflavanone which showed excellent antioxidant activity. 
 
 
 
 
 
Pyran with acetylcholinesterase inhibitor activity 
19)  Jiang et al.,49 (2005) synthesized 3-N-aminomethyl-6-substituted 
phenyl-2H-pyran-2-one . The synthesized compound was shown 
selective potent acetylcholinesterase inhibitor activity. 
OO
NH
CH3
R
R = 2-Br-C6H4, 3,4- (OCH3)2-C6H3 
 
 
SCHIIF’S BASES 
O
N
NH
N
N
O
O
O
OH
OCH 3
OH
OOH
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Schiff’s base with antimicrobial activity 
1)  Singh et al.,50 (2006) synthesized 2-(2'-o-hydroxy arylideneimino-
1'-3'-thiazol-4'yl) aminopyridine which showed antibacterial activity 
against Staphylococcus aureus, Escherichia coli and antifungal 
activity against Candida albicans, Candida krusei, Candida 
glabrata, Aspergillus fumigatus. 
 
 
 
 
 
 
 
2)  Suryavanshi et al.,51 (2006) synthesized Naptho[1,2-b]pyrano[3,4-
d]thiazol-8-yl(3-imino-2-oxo)-1H-indole as an intermediates for the 
synthesis of 2-azetidinone and thiazolidinone derivatives, the 
synthesized Schiff’s bases were shown antibacterial activity against 
Staphylococcus aureus, Escherichia coli,. 
N
NH N
S
N
R
R = O-hydroxyphenyl
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3)  Asati et al.,52 (2006) synthesized Arylidene acetohydrazido 
benzotriazoles as an intermediates for the synthesis of 
thiazolidinone derivatives. The synthesized imino compounds were 
shown antibacterial activity against Bacillus subtilis, Escherichia coli 
and antifungal activity against Aspergillus niger, Candida albicans, 
Candida panical. 
 
 
 
 
 
 
4)  Narayana et al.,53 (2006) were synthesized 2-Methyl/ethyl-3-
N
N
N NH
N Ar
O
3a-c 3a : Ar = 4-CH3 C6H4
3b : Ar = 2-CH3 C6H4
3c : Ar = 3-CH3 C6H4
O S
N
N
N
H
O
R1
R2
2a-d
2a : R1 = H , R2 = H
2b : R1 = H , R2 = Br
2c : R1 = H , R2 = OH
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{[(aryl)methyl-ene]amino}-5,6,7,8-tetrahydro[1]benzothieno[2,3-
d]pyrimidin-4(3H)-ones. The synthesized intermediates were shown 
antibacterial activity against Escherichia coli, Pseudomonas 
aeruginosa, Staphylococcus aureus and antifungal activity against 
Aspergillus fumigatus, Aspergillus flavus. 
    
 
 
 
 
 
5)  Rajendran et al.,54 (2002) synthesized Schiff’s base of 8-Methyl-3-
amino-2H-pyrano[2,3,-b]quinolin-2-one. The synthesized compound 
was shown antifungal activity against Aspergillus niger, Fusarium 
species. 
  
 
6)  Naik et al.,55 (2006) synthesized 2-N-(substituted 
benzylidene)imino-4-(coumarin-3-yl)thiazoles (3a-c).the synthesized 
Schiff’s bases were active against Staphylococcus aureus, Bacillus 
subtilis, Escherichia coli. 
  
 
S
N
N
O
R
N
Ar
R = -CH3 or -C2H5
Ar = 4-CH3 or 4-OCH3 or 3-OCH3
N OCH3 O
N C6H5
O O
N
S
N R
3a-c
3a : R = 3-OCH3
3b : R = 3,4,5-(OCH3)3
3c : R = 4-N(CH3)3
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Schiff’s base with antioxidant activity 
7)  Yuksek et al.,56 (2006) synthesized 3-Alkyl(aryl)-4-(3,4-
dihydroxybenzylidenamino)-4,5-dihydro-1H-1,2,4-triazol-5-ones.The 
synthesized compounds were shown antioxidant activity. 
N
N
H
N N
OH
OH
R
O
R = -CH3, -C2H5, -CH2-C6H4-Cl  
 Schiff's base with analgesic activity: 
8)  Asati et al.,52 (2006) synthesized Arylidene acetohydrazido 
benzotriazoles as an intermediates for the synthesis of 
thiazolidinone derivatives. The synthesized imino compounds were 
shown analgesic activity in albino rats by Eddy and Leimbach 
method. 
 
 
 
N
N
N NH
N Ar
O
3 3a : Ar = 4-CH 3 C
3b : Ar = 2-CH 3 C
3c : Ar = 3-CH 3 C
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Schiff’s Base with Antitubercular Activity 
9)  Vasoya et al.,57 (2005) synthesized- 2-[(4'-Hydroxy-3'-
methoxyphenyl)-hydrazinocarbonyl]-3-chloro-5-phenoxybenzo[b]-
thiophenes (2e). The synthesized compounds showed 
antitubercular activity. 
 
 
 
 
Schiff’s base with anti-inflammatory activity 
10)  Narayana et al.,58 (2006) synthesized 2-Methyl/ethy 
l-3-{[(aryl)methyl-ene]amino}-5,6,7,8-tetrahydro[1]benzothieno[2,3-
d]pyrimidin-4(3H)-one. The synthesized intermediates were shown 
excellent anti-inflammatory activity. 
S
N
N
O
R
N
Ar
R = -CH3 or -C2H5
Ar = 4-CH3 or 4-OCH3 or 3-OCH3
 
 
 
 
 
O
S
Cl
NH N
R
O
R = N-(CH3)2-C6H4 or 4'-Cl-C6H4 or 4'OH,3'-OCH3-C6H3
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CHEMISTRY  
CHALCONES 
General Reactions 
Nucleophilic addition reaction59 
 From the resonance structure of an α, β-unsarurated carbonyl 
compounds, nucleophilic addition reaction takes place by simple addition 
or conjugate addition. 
Simple Addition: 
  That is one in which nucleophile add across the double bond of the 
carbonyl group. 
Conjugate Addition 
 That is one in which nucleophile add on the β-carbon atom. 
R R
O
R R
O
R R
O
-
+
-
+
Resonance structure of chalcone  
R R
O
+ Nu-
simple addition
conjugate addition
R R
OH
Nu
R R
OHNu
R
ONu
R
enol form ketone form
H
+
H
+
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 Almost all nucleophilic reagents that add at carbonyl carbon of the 
aldehyde or ketone, is also capable of adding at β-carbon of an α,β-
unsaturated carbonyl compound. In many instance conjugate addition is 
the major reaction path. 
 
Mechanism of Chalcone Formation 
ALDOL CONDENSATION60,61 
H
O
R2 R
H
O
R
OH
addition product (aldol)
R
H
O
R
condensation product
-H2O
base
  
 Aldol condensation is a powerful way of making carbon carbon 
bonds. Two aldehyde or ketone react to form initial addition product which 
is a β-hydroxyaldehyde, but these substances usually eliminate water to 
form α,β-unsaturated carbonyl compounds. 
Aldol condensation can occur between 
• Two identical or different aldehydes. 
• Two identical or different ketones. 
• An aldehyde and a ketone. 
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CLAISEN-SCHMIDT REACTION 
 It is the condensation of aromatic aldehyde having no α-hydrogen 
with aromatic ketones or ester having α-hydrogen, in the presence of 10% 
alkali solution to give α,β-unsaturated aldehyde or ketone is known as 
CLAISEN-SCHMIDT REACTION. 
MECHANISM 
Step-1: 
 A strong base abstract the acidic α-hydrogen atom from the 
carbonyl compound to give resonance stabilized enolate ion. 
 
Step-2: 
 The resulting anion can react with the carbonyl carbon of another 
molecule through a nucleophilic addition reaction to produce an 
intermediate alkoxide. 
 
 
 
H5C6 H
O
+
H2C H
O
- H5C6
O
H
O-
R CH2
O
H
alpha hydrogen
OH
R CH2
O
-
R CH2
O
-
enolate ion
+ OH2
-
Chapter 6          
Spectral Studies 
 43
Step-3: 
 The intermediate alkoxide deprotonate water molecule to produce a 
hydroxide ion and a compound that contains both a carbonyl moiety and –
OH group called an aldol. 
. 
Step-4: 
 Hydroxide ion functions as a base and removes an acidic α-
hdrogen giving the reactive enolate. 
 
 
 
Step-5 
 The electrons associated with the negative charge of the enolate 
are used to form the C=C and displace the leaving group, regenerating 
hydroxide ion giving the conjugated aldehyde. 
H5C6 CH
OH
H
O
-
H5C6 H
O
+ OH-
 
 
H5C6
OH
H
O
H
OH
-
H5C6 CH
OH
H
O
-
H5C6
O
H
O-
H
O
H
H5C6
OH
H
O
Aldol
+ OH-
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PYRANS62,63 
 Six membered oxygen heterocycles constitute a group of 
compounds which occurs widely throughout the plant kingdom 
Structure                    :  
 
Molecular formula       :       C5H6O 
Molecular weight         :       82.10 
 Here the main discussion is about 4H-pyran. 
  Six membered oxygen heterocycles constitute a group of 
compounds which occur widely throughout the plant kingdom. According 
to the position of unsaturated carbon atom, the pyran heterocycles can be 
classified as 2H-pyran and 4H-pyran. 
 
 
 
 
NOMENCLATURE 
 All the compounds are discussed based on three molecules: 2H-
pyran, 4H- pyran, and the pyrylium cation. 
 
 
 
 
O H
H
2H-pyran
O
HH
4H-pyran
O H
H
2H-pyran
O
HH
4H-pyran
O
pyrylium cation
+
O
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 Names which have been used for the benzologue of 2H-pyran 
includes: 2H-1-benzo-pyran, benzo-α-pyran, chrom-3-ene and 2H-
chromene. A similar situation exists for corresponding derivatives of 4H-
pyran. The benzologue of pyrylium cation is known both as benzopyrylium 
and chromylium.  
 
GENERAL REACTIONS 
Substitution reaction 
a)  Electrophilic substitution reaction: 
  Electrophilic substitution reaction usually takes place at position 3rd 
and/or 5th position where a relatively high π-electron density is located in 
all pyran like heterocycles. 
Bromination 
  2,4,4,6-tetraphenyl-4H-pyran easily gave 3,5-dibromo derivative in 
the presence of bromine in carbon disulphide. 
 
 
 
 
O
PhPh
Ph Ph
bromine in carbondisulphide
O
PhPh
Ph Ph
Br Br
O
2H-chromene
(2H-1-benzopyran)
O
4H-chromene
(4H-1-benzopyran)
O
1-benzopyrylium
+
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Alkylation, Acylation and silylation 
 Unsubstituted 4H-pyran and its 4-methyl derivatives were converted 
with a butyllithium potassium tert-butoxide mixture to corresponding 4H-
pyran-2-yl-potassium intermediates capable of alkylation or silylation to 2-
substituted-4H-pyran. 
O
RH
O
RH
K O
RH
R'
R'-X
R = H,Me R' = MeI  
 4H-pyran in the presence of sodium amide in liquid ammonia or 
with tert-butyllithium in tetrahydrofuran, an anionic species has been 
formed which was easily alkylated or acylated with methyl iodide,benzyl 
chloride exclusively at 4th position. 
O
Ph
Ph Ph
tert-butyllithium in THF
O
Ph
Ph Ph
- RCOCl
O
Ph
Ph Ph
COR
 
b)  Nucleophilic substitution reaction 
Hydrolysis 
 2,4,4,5-tetrachloro-4H-pyran easily hydrolyzed with water to get 2,3-
dichloro-4-pyrone. 
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O
Cl
Cl
Cl
Cl H2O
O
O
ClCl
 
 2,2-dimethoxy-6-phenyl-2H-pyran with sodium hydroxide in DMF 
gives 6-phenyl-2-pyrone. 
OPh OCH3
OCH3
NaOH in DMF
OPh O 
 
c)  Conversion to other heterocycles 
 Conversion to 1,4-dihydropyridines: 
O
H CH
CHOOHC
RNH2
N
R
H CH
CHOOHC
R = H or CONH2,  
 A large number of 1,4-dihydropyridines were prepared from  
3,5-diformyl-4-ethynyl-4H-pyran in the presence of primary amines, 
ammonium acetate, urea. 
Ring contraction: 
 The oxidation of 2-substituted 3,4,5,6-tetrachloro-2H-pyran with 
molecular oxygen at 20oC was accompanied by contraction of six 
membered ring to 2-furylcarbonyl chloride. 
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O
Cl
ClCl
Cl R
O2
O
Cl Cl
ClClOC
 
Ring expansion 
 Decomposition of 2-azido-2H-pyran generates seven membered 
heterocyclic systems.  
O
R
PhPh
Ph N3
Ph
N
O
PhR
Ph
Ph Ph
R = H or Ph  
 
d)  Ring opening reaction 
Reaction of 4H-pyran with Amines, Hydrazine, Hydroxylamines: 
 Unsubstituted 4H-pyran with 2,4-dinitrophenyl hydrazine afford 
identical bishydrazones. 
O
R
NH
N N
NH
R
2,4-dinirophenyl hydrazine
 
e)  Oxidation 
 Pyran with oxidizing agents in acidic medium leads to 
corresponding pyrylium salts. Unsubstituted 4H-pyran as well as its methyl 
derivatives react with trityl perchlorate or with phosphrous pentachloride to 
give pyrylium salts. 
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f)  Reduction 
 Partial hydrogenation of corresponding 2H-pyran to give 
dihydropyran derivative 
 Hydrogenation of unsubstituted 4H-pyran with the help of Palladium 
or Adam platinum catalyst gives tetrahydropyran derivatives. 
 
O
CH3
CH3
CH3
CH3
CH3
Raney nickel or platinum
O
CH3 H
CH3
CH3
CH3
CH3
H
 
 
O O
Raney nickel or platinum
 
g)  Photochemical reaction 
 Photolysis of 4,4-diphenyl-4H-pyran in tert-butyl alcohol gave a 
mixture of unsaturated aldehyde and other compounds.  
O
Ph Ph
O
Ph H
Ph
CHO
Ph
Ph
Ph
Ph
COOR
R = H, t-but  
 
O
PCl5
or trityl perchlorate
O
+
ClO4
-
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MECHANISM INVOLVED IN THE SYNTHESIS OF CYANOPYRAN64-69 
 Synthesis of cyanopyran has been carried out by Michael reaction 
of chalcone followed by an intramolecular cyclization. 
Step-1: 
 Base facilitates production of anion from malononitrile.(Base: 
Sodium ethoxide, pyridine, piperidine) 
 
 
  
Step-2: 
 Conjugate addition of anion to the α,β-unsaturated carbonyl 
compound, followed by acceptance of a proton from alcohol to give an 
enol form which finally tautomerises to keto form.  
NC
CH
NC
- + R R1
O
R R1
OCH
CNNC -
R R1
OHCH
CNNC
enol form
R R1
OCH
CNNC
keto form
H
+
 
 
NC
CH2
NC
+ C2H5O-
NC
CH
NC
- + C2H5OH
basemalononitrile
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Step-3 
 Enolic form of the Michael adduct undergoes nucleophilic 
intramolecular addition of hydroxy group to cyano group to form cyclic 
intermediate, which tautomerises to form 2-amino-3-cyano-4,6-
disubstituted pyran. 
R R1
OHHC
C
N
NC
R R1
OHHC
C
N
NC
-
+ .... OHCH
R R1
N
NC
+
OCH
R R1
NH
NC
O
R R1
NH2
NC
tautomerisation
-
 
 
 
 
 
 
Chapter 6          
Spectral Studies 
 52
MECHANISM INVOLVED IN THE SYNTHESIS OF CARBOETHOXY 
PYRAN: 
 Synthesis of carboethoxypyran has been carried out by Michael 
reaction of chalcone followed by an intramolecular cyclization. 
Step-1 
 Base facilitates production of anion from ethyl cyanoacetate. 
 ( Base: Sodium ethoxide, pyridine, piperidine) 
NC
CH2
H5C2OOC
+ C2H5O-
NC
CH
H5C2OOC
- + C2H5OH
baseethyl cyanoacetate  
Step-2 
 Conjugate addition of anion to the α,β-unsaturated carbonyl 
compound, followed by acceptance of a proton from alcohol to give an 
enol form which finally tautomerises to keto form.  
NC
CH
H5C2OOC
- + R R1
O
R R1
OCH
CNH5C2OOC -
R R1
OHCH
CNH5C2OOC
enol form
R R1
OCH
CNH5C2OOC
keto form
H
+
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Step-3 
 Enolic form of the Michael adduct undergoes nucleophilic 
intramolecular addition of hydroxy group to cyano group to form cyclic 
intermediate, which tautomerises to form 2-amino-3-carboethoxy-4,6-
disubstituted pyran. 
R R1
OHHC
C
N
H5C2OOC
R R1
OHHC
C
N
H5C2OOC
-
+ .... OHCH
R R1
N
H5C2OOC
+
-
OCH
R R1
NH
H5C2OOC
O
R R1
NH2
H5C2OOC
tautomerisation
 
SYNTHESIS OF PYRANS 
1)  From α-cyanochalcone69: 
 The reaction of ethyl cyanoacetate with α-cyanochalcone in the 
presence of a base piperidine leads to the formation of β-enaminoester via 
Michael addition followed by cyclization to give pyrans 
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Ph
COPh
CN
+ NC
COOC2H5 OPh NH2
COOC2H5
Ph
NC
Piperidine
  
2) From Ketene dithioacetal70 
 The synthesis of 2H-pyran-2-one derivatives by the reaction of 
various type of acetyl compounds with ketene dithioacetal (methyl-2-
cyano-3,3-bis(methylthio)acrylate in the presence of powdered potassium 
hydroxide in N,N-dimethyl formamide. 
 
3) From Acrylonitrile derivatives (α,β-unsaturated nitrile)71 
 The reaction of α,β-unsaturated nitrile with ethyl acetoacetate in 
ethanol in the presence of piperidine give corresponding polyfunctional 
pyran derivatives. 
MeS
MeS COOMe
CN
+ R
CH3
O
KOH in DMF
O O
CN
SMe
R
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R
X
CN Ethyl acetoacteate 
In ethanol
O
NC COOEt
H2N CH3
R
acetylacetone
ONH2
NC
R
COCH3
CH3
R = 
X = CN or COOC2H5 
R = 2-thienyl or 2-furyl
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4) From crotonyl cyanide72: 
 The reaction of crotonyl cyanide with ethyl vinyl ether or butyl vinyl 
ether at room temperature give 2-alkoxy-3,4-dihydro-2H-pyran-6-
carbonitrile in quantitative yield. 
CN
OR2
R1
+
R3
OR4 ONC
R2
R1 R3
OR4 
5)  From Diethyl malonate73: 
 The appropriately substituted diethyl malonate is heated with methyl 
cis -2-chloroacrylate in tetrahydrofuran. The resulting triester were 
saponified , acidified, decarboxylated to give substituted pentenedioic acid 
followed by reflux with acetyl chloride to get 3-alkyl-6-chloro-2-pyrone. 
EtOOC
COOEt
R
+
COOMe
Cl
OCl O
R
CH3COCl
 
6)  From ethyl phenylpropiolate74: 
 The reaction between ethyl phenylpropiolate and suitable ketone in 
1:1 molar ratio in dry ether at 00C using sodium ethoxide as a base, then 
the reaction mixture was treated with zinc acetate and hydrochloric acid to 
form acetylenic β-diketones, which on heating underwent cyclization to 
give 4H-pyran-4-one. 
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Ph
COOC2H5 + CH3
R
O
C2H5ONa
Ph R
O ONa
Zn(AcO)2
HCl
Ph
O
R
O
O
O
RPh  
7)  From α-napthol or β-napthol75: 
 One pot condensation of aryl aldehyde, α-napthol or β-napthol and 
malononitrile in the presence of catalytic amount of 
tetrabutylammoniumbromide heated under Microwave oven. 
CHO
R +
CN
CN
+
OH
O
R
NH2
CN
TBABr
MW,H2O
 
8) From salicyladehyde77: 
 The reaction of salicyladehyde with different active methylene 
compounds gives arylidene intermediate by Knoevenagel condensation, 
followed by cyclization to give substituted benzopyran. 
OH
CHO
+
NC
NC
OH
CNNC
O
CN
O
Chapter 6          
Spectral Studies 
 58
9)  From 1,3-cyclohexadione78 
 A mixture of an aldehyde, 1,3-cyclohexadione derivative and an 
active methylene compound was stirred at room temperature in the 
presence of an ionic liquid 1-butyl-3-methylimidazolium hydroxide for a  
certain period of time to give benzo[b]pyran derivatives. 
O
O
R
R
+ R' CHO +
NC
R''
R'' = CN, COOEt
O
O R'
R''
NH2
R
R   
10)  From Homopropargylic alcohol79 
CHO
+ CH OH
BiCl3
MW
O
Cl
Ph  
 Various aldehydes or ketones were reacted with homopropargylic 
alcohol in the presence of bismuth chloride under microwave irradiation 
will give 4-chloro-5,6-dihydro-2H-pyran. 
11) Cycloaddition reaction80 
 2-Methoxy-6-methyl-3,4-dihydro-2H-pyran synthesized by (4+2) 
cycloadditon reaction from corresponding vinyl ketones and  alkyl vinyl 
ether. 
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CH2
R1 O
+
R3
OR2 O OR2R1
R3
R1 = CH3, R2 = CH3 , R3 = H  
12)  Maitlan-Japp reaction81 
  Condensation of two different aldehyde and a derivative of a β-
ketoester in the presence of a lewis acid to form tetrahydropyran-4-one in 
excellent yield. 
MeO
R
O O
R' CHO MeO OH
O O
R
R'
R'' CHO
MeO OH
O O
R
R'
R''
O
MeOOC R
R'' R'
O
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SCHIFF’S BASE82 
GENERAL METHODS FOR THE FORMATION OF C=N BONDS: 
a)  Amine carbonyl condensations: 
 The classic method for the introduction of the carbon nitrogen 
double bond into the molecule involves the condensation of aldehydes and 
ketones with a variety of amino compounds (amines, hydroxylamines, 
hydrazines) followed by elimination of elements of water to give 
corresponding azomethines. 
R1
R2
O +R3 NH2
R1
R2
N
R3
HOH R1
R2
N
R3
+ OH2
R1,R2 = H, alkyl, aryl
R3 = alkyl, aryl, OH,OR,NHR  
 
b) Condensation reaction involving active methylene 
compounds: 
 Aromatic nitroso compounds undergo base catalyzed condensation 
with active methylene compounds to give intermediate adducts 
(hydroxylamine derivatives) which can be dehydrated to azomethines. 
 
N O
Ar
+
R1
R2
base
Ar
N
R2
R1OH
OH2-
Ar
N
R2
R1
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c)  Dehydrogenation (oxidation) of amino compounds to 
 azomethines: 
 The dehydrogenation of primary or secondary alkylamines over 
nickel, platinum, chromium catalysts or in contact with sulphur, or selenium 
gives acceptable yields of corresponding azomethines. 
Reagent used: Hydride transfer reagents (diazonium fluoroborates, trityl 
perchlorate) 
 
 
 
d)  Elimination reaction leading to azomethines: 
 Thermal and base catalyzed elimination of substrates derived by 
electrophilic attack (halogenations, nitrosation, nitration, sulphonation) at 
the nitrogen atom of primary and secondary alkylamines. 
R1
R2
N
X
R3
H
base or heat
R1
R2
N
R3
-HX
 
GENERAL REACTION 
a)  Reaction with electrophiles 
 Electrophiles attack predominantly at nitrogen atom in the 
azomethines. 
 
R1
N
R2 R4
R3 R1
N
+
R2 R4
R3
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Halogenation 
 Halogens are reported to add in a 1,2-fashion to the carbon-
nitrogen double bond in N-arylaldimines. The product of the reaction of 
benzylidene aniline with bromine in carbon tetrachloride is formulated as 
an N-bromoiminium bromide. 
Ph N
Ph + Br2 Ph N+ Ph
Br
Br-
 
Alkylation: 
 Direct alkylation of N-alkyl aldimines and ketimines occurs at the 
nitrogen atom to give corresponding iminium salt. N-alkylation of N-
monosubstituted hydrazones has been applied intramolecularly providing 
a general route to pyrazolines. 
X
N
NH
R4
R1
R2
R3
N
N
R3R1
R2
R4
-HX
 
Acylation: 
 Acylation of schiff’s base by acid anhydrides, acid chlorides, and 
acyl cyanides is initiated by attack at the nitrogen atom and leads to net 
addition of acylating agent to the carbon nitrogen double bond. 
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N
HAr
Ph
+
Cl2HC
CH3
O
C
N
+
HAr
Ph
O
CCl2
-
Et3N
N
O
Ar
Ph
Cl
Cl
 
b) Reaction with nucleophiles 
 Nucleophilic reagents attack azomethines at imidyl carbon atom.  
1)  Alkoxide adds to schiff’s base giving corresponding α-alkoxyamino 
 compounds. 
N
O
R
R
PhOCH2CON
MeOH
N
O
R
R
PhOCH2CON
OMe
 
2)  Addition of hydrogen cyanide to schiff’s base occur readily and 
provides a viable route to α-amino nitriles, which can inturn be used 
as the precursors for the synthesis of α-aminoacids.   
3) Reaction with Grignard reagents: Schiff’s base lacking hydrogen 
atoms α to the carbon nitrogen double bond react with Grignard 
reagents to give adducts which on hydrolytic workup afford 
secondary amine in excellent yield. 
R1
R2
N
R3
R4MgX
N
R4
R2
R1
XMg
R3
NH
R4
R2
R1
R3
 
4)  Reaction with active methylene compounds: Schiff’s base react 
readily with active methylene compounds to give adducts which 
tend to eliminate the elements of an amine affording the 
Chapter 6          
Spectral Studies 
 65
corresponding alkene. 
N
HAr
R
+
X
Y
N
H
Ar
X Y
R H
Ar Y
X
-RNH2
 
c)  Oxidation 
 Oxidation of schiff’s base with a peroxy acid results in cleavage of 
carbon nitrogen bond to give a carbonyl compound and a nitroso 
compound. On the other hand oxidation using peroxy acid at low 
temperature (0oc) affords an excellent synthetic route to oxaziridines. 
R1
R2
N
R3
R4COOOH
O
N
R1
R2
R3
 
d)  Reduction 
 Alkali metals in inert solvents such as ether or toluene tend to 
promote reductive dimerization by a radical coupling mechanism to afford 
diamino compound as a major product.   
 
R1
Ar N
R2
Ph
R1
Ar N
R2
Ph
-.
R1
Ar NH
R2
Ph
20
R1
Ar
NH
R2
Ph
R1
Ar
NH
Ph
R2
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 Metal proton reagents (Sodium, Sodium amalgam, Magnesium, 
Aluminum in ethanol etc.) smoothly reduce Schiff's base to corresponding 
amines. 
MECHANISM 
 Imines are prepared by a reaction between a carbonyl compound 
and a primary amine. If the imine contains a hydrogen atom, it is unstable 
and usually cannot be isolated. However when the imine contains aromatic 
group on the nitrogen, the resulting imine is stable and can be isolated. 
The products are called schiff’s bases. 
Step-1: 
R1
C
R2
O + NH2 R3
..
R1
R2
N
+
OH
R3
H
-
R1
R2
N
OH
R3
H
carbinolamine intermediate
  
 Nucleophilc addition of the amine to the carbonyl compound 
followed by transfer of a proton from nitrogen to oxygen leads to the 
formation of tetrahedral carbinolamine intermediate. 
Step-2: 
 Elimination of water to gives the corresponding azomethines. 
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PURPOSE OF WORK 
 Antimicrobial agents are the most commonly used and misused 
drugs. The main consequence of the widespread use of antimicrobial 
agents leads to the emergence of antibiotic resistant pathogens. This 
situation fueling an ever increasing needs for new drugs. 
OBJECTIVES 
1.  To synthesize new derivatives and evaluating their possible 
antimicrobial activity. 
2.  To study the minimum inhibitory concentration of the highly active 
 compounds. 
3.  To synthesis highly potent, less toxic compounds. 
4.  To remove untoward side effects and to prevent development of 
 resistance by infectious microorganisms. 
AIM 
 From the literature survey, six membered heterocyclic compounds 
containing one oxygen atom such as 4H-pyran or 4H-pyrone constitute an 
important class of various natural and synthetic products which possess 
antibacterial, antifungal, antioxidant, anti-HIV and anti-tumor activity. 
  
 From the literature review, it was found that various heterocyclic 
rings and substituted phenyl groups in the pyran ring shows various 
biological activities. It was also reveals that schiff's bases show different 
biological activities. In the light of these observations, the purpose of work 
Chapter 6          
Spectral Studies 
 69
is to synthesize cyano pyrans, carboethoxy pyrans and it's Schiff's bases 
through appropriate synthetic routes and to screen their biological activity. 
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EXPERIMENTAL WORK 
1.   MATERIALS AND METHODS 
Chemicals used 
 Substituted acetophenone (p-nitro acetophenone, p-chloro 
acetophenone, p-fluoro acetophenone, p-methyl acetophenone, p-
methoxy acetophenone), Sodium Hydroxide, Glacial Acetic Acid, 
Furfuraldehyde, p-dimethyl amino benzaldehyde, methanol, dioxan, 
pyridine. 
 All the chemicals were procured from Hi-media, Sigma Aldrich, 
S.D.Fine Chemicals Ltd, and Loba Chemicals Pvt. Ltd. All the compounds 
procured were purified and dried using standard methods before use. 
Apparatus used 
 Beakers (100 and 250ml), RBF, reflux condenser, guard tube, test 
tubes, conical flask, glass rods, mechanical stirrer, TLC plates, pipettes 
and heating mantle.   
Analytical work 
 Melting points were determined by using melting point apparatus 
MR-VIS, Visual Melting Range Apparatus, LABINDIA and were 
uncorrected. 
 Reactions were monitored by thin layer chromatography (TLC) on a 
precoated silica gel G plates using Iodine vapour as visualizing agent. 
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         Purity of the compounds were recorded on JASCO V-530 UV/VIS 
spectrophotometer in the Department of Pharmaceutical Analysis, College 
of Pharmacy, SRIPMS, Coimbatore-641 044. 
 IR spectra were recorded on JASCO FTIR-420 Series, Department 
of Pharmaceutical Analysis, College of Pharmacy, SRIPMS, Coimbatore-
641 044. 
 PMR spectra were recorded on BRUKER FT-NMR, Shastra 
University, Thanjur. 
 Mass spectra were recorded on Shimadzu, LCMS 2010 EV from 
the Department of Pharmaceutical Analysis, College of Pharmacy, 
SRIPMS, Coimbatore-641 044. 
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2.  SYNTHETIC WORK 
    SCHEME-1 
Step 1: Synthesis of various chalcone derivatives25 
 An ethanolic solution of 0.01 mol aldehyde and 0.01 mol of p-
substituted acetophenone in the presence of catalytic amount of 30% KOH 
was stirred for 24 hrs. The resulting solution was then poured over 
crushed ice, the separated solid was filtered and recrystallized. The purity 
of the compound was established by getting a single spot on TLC plates. 
The melting points were determined and uncorrected.  
Step 2: Synthesis of cyanopyran derivatives25 
          A mixture of above prepared chalcone (0.01 mol) and malononitrile 
(0.01 mol) dissolved in pyridine (20 ml) was heated under reflux for 10 hrs 
in an oil bath. The reaction mixture was cooled and poured over crushed 
ice. The product was isolated and recrystallized. The purity of the 
compound was established by getting a single spot on TLC plates. The 
melting points were determined and uncorrected.  
Step 3: Synthesis of Schiff’s base83 
 The Equimolar mixture of aldehyde and cyanopyran in dioxan was 
heated under reflux for 6 hrs in presence of few drops of glacial acetic 
acid. The reaction mixture was cooled and poured in crushed ice. The 
product was filtered and recrystallized. The purity of the compound was 
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established by getting a single spot on TLC plates. The melting points 
were determined and uncorrected.  
     
    SCHEME-1 
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R''6 CHO+R' COCH3
NaOH , Stirring 
R''6
R'
O
O NH2
CN
R''6
R'
malononitrile
pyridine
O N
CN
R''6
R'
Cl
FCPS and DCPS series
Schiff's base of cyanopyran
R'1     -NO2
R'2     -Cl
R'3     -F
R'4     -CH3
R'5     -OCH3
10 hr reflux 
4-chlorobenzadehyde
2 drops of glacial acetic acid
6 hr reflux
R''6     2-Furyl or  4-dimethyl aminophenyl
5-1
5-1
5-1
5-1
 
    SCHEME-2 
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Step 1: Synthesis of various chalcone derivatives25 
 An ethanolic solution of 0.01 mol aldehyde and 0.01 mol of p-
substituted acetophenone in the presence of catalytic amount of 30% KOH 
was stirred for 24 hrs. The resulting solution was then poured over 
crushed ice, the separated solid was filtered and recrystallized. The purity 
of the compound was established by getting a single spot on TLC plates. 
The melting points were determined and uncorrected 
 
Step 2: Synthesis of carboethoxypyran derivatives25,27 
          A mixture of above prepared chalcone (0.01 mol) and 
ethylcyanoacetate (0.01 mole) dissolved in pyridine (20 ml) was heated 
under reflux for 10 hrs in an oil bath. The reaction mixture was cooled and 
poured over crushed ice. The product was isolated and recrystallized. The 
purity of the compound was established by getting a single spot on TLC 
plates. The melting points were determined and uncorrected.  
Step 3: Synthesis of Schiff’s base83 
  The Equimolar mixture of aldehyde and cyanopyran in 
dioxan was heated under reflux for 6 hrs in presence of few drops of 
glacial acetic acid. The reaction mixture was cooled and poured in crushed 
ice. The product was filtered and recrystallized. The purity of the 
compound was established by getting a single spot on TLC plates. The 
melting points were determined and uncorrected.  
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    SCHEME-2 
R''6 CHO+R' COCH3
NaOH , Stirring 
R''6
R'
O
O NH2
COOC2H5
R''6
R'
Ethylcyanoacetate
pyridine
O N
COOC2H5
R''6
R'
Cl
FPS and DPS series
Schiff's base of carboethoxypyran
5-1
R'1     -NO2
R'2     -Cl
R'3     -F
R'4     -CH3
R'5     -OCH3
4-chloro benzaldehyde
2 drops of glacial acetic acid
6hr reflux
R''6     2-Furyl or  4-dimethyl aminophenyl
5-1
5-1
5-1
10 hr reflux
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Table: 1 PHYSICAL DATA OF NEWLY SYNTHESIZED 
COMPOUNDS 
O N
R'''
R''
R'
Cl 
 
Compound 
code R' R'' R''' 
Molecular 
weight 
Molecular 
formula 
% 
yield 
Rf 
value 
Melting 
point 
FCP1S -NO2 431.827 C23H14ClN3O4 65% 0.6 180-182 
FCP3S -F 404.320 C23H14ClN2O2 53% 0.63 240-241 
FCP4S -CH3 400.856 C24H17ClN2O2 47% 0.67 165-167 
FCP5S -OCH3 
2-
furyl -CN 
416.856 C24H17ClN2O3 38% 0.72 189-192 
Compound 
code R' R'' R''' 
Molecular 
weight 
Molecular 
formula 
% 
yield 
Rf 
value 
Melting 
point 
DCP1S -NO2 484.933 C27H21ClN4O3 75% 0.66 140-142 
DCP2S -Cl 474.381 C27H21Cl2N3O 81% 0.58 162-163 
D 3  -F 457.926 C27H21ClFN3O 72% 0.63 168-170 
DCP4S -CH3 453.962 C28H24ClN3O 63% 0.74 178-179 
DCP5S -OCH3 
-CN 
469.962 C28H24ClFN3O2 59% 0.57 171-172 
DP1S -NO2 531.986 C29H26ClN3O5 67% 0.65 110-113 
DP2S -Cl 521.434 C29H26Cl2N2O3 73% 0.75 122-125 
DP3S -F 504.40 C29H26ClFN2O3 57% 0.56 130-133 
DP4S -CH3 501.015 C30H29ClN2O3 49% 0.62 120-124 
DP5S -OC
4-
Dimeyl 
amino 
phenyl 
-
COOC2H5 
517.015 C30H29ClFN2O4 63% 0.69 119-120 
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  Recrystallization solvent: methanol except FCP1S (Dioxan + 
Methanol) 
  Solvent system for TLC: Ethyl acetate: n-hexane (6:4) or n-
hexane : Dichloromethane (3:7)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
H3   
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SPECTRAL STUDIES OF THE SYNTHESIZED 
COMPOUNDS 
 
 The structure of the synthesized cyanopyran and carboethoxy 
pyran derivatives were established on the basis of UV, IR, NMR, Mass 
spectral data. The purity of cyanopyran and carboethoxy pyran derivatives 
was established by single spot on TLC plate. 
SPECTRAL DATA OF FCP3S 
Compound code : FCP3S 
Structure : 
O N
O
Cl
F
CN
   
Chemical Name :  2-{[(E)-(4-chlorophenyl)methylidene]amino}-6- 
   (4-fluorophenyl)-4-(furan-2-yl)-4H-pyran-3- 
   carbonitrile 
Molecular formula :  C23H14ClN2O2 
Molecular weight :  404.32 
Percentage yield :  53% 
Melting point :  240-241 oC 
Rf Value :  0.63 
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1) UV/ Visible spectrum: 
 λ-max   : 386 mn    
 Solvent used  : Methanol 
2)  IR SPECTRAL DATA 84,85:  (KBr pellet method) 
Table: 2 IR Spectral Data of FCP3S 
Sl. No Peak Number Types of vibration Frequency (cm
-1) 
1 22 C≡N Stretching 2213.88 
2 23 C=N, C=C Stretching 1604.28 
3 28 C−O−C Stretching 1154.19 
4 17 Aromatic CH Stretching 3116.42 
3)  PMR Spectral data 25,26,85,86 
 The proton magnetic resonance spectrum of the compound FCP3S 
was in full agreement with its molecular formula with regard to proton 
count and chemical shift. 
Table: 3 PMR Spectral Data of FCP3S 
Sl no δ- Value Types of proton Number of protons 
1 2.7 −CH 1 
2 6.9 N=CH 1 
3 7.1-8.1 Aromatic & Heteromatic protons 12 
4)  Mass spectrum 
 Mass spectrum of the compound FCP3S was full agreement with its 
molecular weight. 
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UV Spectrum of FCP3S 
 
 
O N
O
Cl
F
CN
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IR Spectrum of FCP3S 
 
O N
O
Cl
F
CN
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PMR Spectrum of FCP3S 
O N
O
Cl
F
CN
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MASS SPECTRUM OF FCP3S 
 
 
O N
O
Cl
F
CN
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SPECTRAL DATA OF DP3S 
Compound code : DP3S 
Structure :  : 
 
   
  
 
 
Chemical Name :  2-{[(E)-(4
Molecular formula :  C29H26ClF
Molecular weight :  504.24 
Percentage yield : 57% 
Melting point : 130-133 oC 
Rf Value : 0.56 
1)  UV/ Visible spectrum: 
 λ-max : 421 nm    
 Solvent used : Methanol 
 
 
2)  IR SPECTRAL DATA84,85: (KBr pellet method) 
Table: 4 IR Spectral Data of DP3S 
Sl no Peak Number Types of vibration Frequency (cm-1) 
1 20 C=N, C=C, C=O Stretching 1588.09 
2 27 C−O−C Stretching 1087.66 
3 25 C−O Stretching in ester 1227.47 
4 15 Aromatic CH stretching 3195.47 
 
O
COOC2H5
N
Cl
N
CH3CH3
F
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3)  Mass spectrum 
 Mass spectrum of the compound DP3S was full agreement with its 
molecular weight. 
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UV SPECTRUM OF DP3S 
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IR SPECTRUM OF DP3S 
O
COOC2H5
N
Cl
N
CH3CH3
F
O
COOC2H5
N
Cl
N
CH3CH3
F
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MASS SPECTRUM OF DP3S 
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COOC2H5
N
Cl
N
CH3CH3
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ANTIMICROBIAL SCREENING 87-89 
 
APPARATUS AND CHEMICALS REQUIRED 
  
Sterile discs :  Hi Media 
Standard discs of drugs :  Hi Media 
Sterile swab :  Hi Media 
Non- absorbent cotton :  Rama Raju Surgical cotton Ltd. 
Conical flask (250 ml) :  Borosil 
Test Tubes :  Borosil 
Petri dishes :  SD Fine - Chem Ltd. 
Micropipettes :  VARI pipettes (Hi- Tab Lab) 
Hot air oven :  Technico Equipments 
Autoclave :  Universal Autoclave 
Laminar Flow Unit :  CLEAN AIR Instruments Inc. 
Incubator :  Technico Incubator 
Micro tips :  Tarsons 
 The antibacterial and antifungal screening were carried out in the 
Pharmaceutical Biotechnology Laboratory, College of Pharmacy, SRIPMS, 
Coimbatore. 
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SCREENING FOR ANTIBACTERIAL ACTIVITY 
 
Media     :  Mueller- Hinton agar 
 Mueller Hinton broth gelled by the addition of 2% agar 
(bacteriological grade). 
Ingredients 
Casein enzymic hydrolysate  :     17.5 gm/Ltr 
Beef infusion  :      300gm/ Ltr 
Soluble starch  :      1.5 gm/ Ltr 
Final pH at 250C                    :       7.4 ± 0.2 
Preparation 
 The ingredients were dissolved in distilled water with the aid of heat 
and pH was adjusted to 7.2 - 7.6 using alkali or dilute acid. 
Sterilization 
 15-20ml of Mueller Hinton agar was transferred to test tubes and 
sealed with non-absorbent cotton. It was then autoclaved at a pressure of 
15 psi (121oc) for not less than15 minutes. 
Organisms used 
 Staphylococcus aureus NCIM 5021, Bacillus subtilis NCIM 2010 
Proteus vulgaris NCIM 2027 and Pseudomonas aeruginosa  NCIM 5029 
were collected from the National Chemical Laboratory, Pune and stored in 
the Pharmaceutical Biotechnology Laboratory, College of Pharmacy, 
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SRIPMS, Coimbatore-44. The strains were confirmed for their purity and 
identity by Gram’s staining method and by their characteristic biochemical 
reactions. The selected strains were preserved by sub culturing them 
periodically on nutrient agar slants and storing them under frozen 
conditions. For the study, fresh 24 hr broth cultures were used after 
standardization of the culture. 
Working conditions 
 The entire work was done using horizontal laminar flow hood so as 
to provide aseptic conditions. Before commencement of the work air 
sampling was carried out using a sterile nutrient agar plate and exposing it 
to the environment inside the hood. After incubation it was checked for the 
growth of microorganism and absence of growth confirmed aseptic 
working conditions. 
Preparation of Inoculum   
 The inoculum for the experiment was prepared fresh in Mueller 
Hinton broth from preserved frozen slants. It was incubated at 37 oC for 
18-24 hrs and used after standardization. 
Drugs used :    Schiff's bases of Cyano pyrans, Carboethoxy pyrans 
Standard used :   Ciprofloxacin (5 mcg /disc) 
Vehicle used :   N,N, Dimethyl formamide 
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ANTIBACTERIAL SCREENING BY KIRBY-BAUER METHOD 
 Mueller Hinton agar plates were prepared aseptically to get a 
thickness of 5-6 mm. The plates were allowed to solidify and inverted to 
prevent the condensate falling on the agar surface. The plates were dried 
at 37oC before inoculation. The organism was inoculated in the plates 
prepared earlier, by dipping a sterile swab in the previously standardized 
inoculum, removing the excess of inoculum by pressing and rotating the 
swab firmly against the sides of the culture tube above the level of the 
liquid and finally streaking the swab all over the surface of the medium 3 
times, rotating the plates through an angle of 60o after each application. 
Finally the swab was pressed round the edge of the agar surface. It was 
allowed to dry at room temperature, with the lid closed. The sterile disc 
containing test drugs, standard and blank were placed on the previously 
inoculated surface of the Mueller Hinton agar plate and it was kept in the 
refrigerator for one hour to facilitate uniform diffusion of the drug. Plates 
were prepared in triplicate and they were then incubated for 18-24 hrs. 
Observations were made for zone of inhibition around the drugs and 
compared with that of standard. All the compounds synthesized were 
tested for antibacterial activity against gram-positive and gram-negative 
bacteria. 
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Table: 5 QUANTITATIVE SCREENING OF THE TEST COMPOUNDS 
FOR ANTIBACTERIAL ACTIVITY AGAINST 
GRAM POSITIVE ORGANISMS 
 
Diameter of Zone of Inhibition in mm 
Staphylococcus aureus NCIM 
5021 
Bacillus subtilis 
NCIM 2010 
Sl. 
No. 
Compound 
Code 
1000mcg/disc 500mcgg/disc 1000mcg/disc 500mcg/disc
1 FCP1S 20 16 17 13 
2 *FCP3S  21  20 
3 FCP4S 21 15 19 15 
4 FCP5S 17 13 17 14 
5 DCP1S 18 15 15 13 
6 DCP2S 17 14 20 16 
7 *DCP3S  22  26 
8 *DCP4S  17  19 
9 *DCP5S  22  17 
10 DP1S 22 15 19 16 
11 *DP2S  18  23 
12 DP3S 19 14 21 16 
13 DP4S 17 14 19 15 
14 DP5S 16 13 16 14 
15 Blank (DMF) - - - - 
16 
Standard 
Ciprofloxacin 
(5 mcg/disc) 
 
36 36 
(-) indicates no zone of inhibition 
Zone diameter: 18 and above- Sensitive, 12-17-Moderately sensitive, <12- 
Resistant  
* Compounds were screened only at concentration of 500 mcg/ disc. 
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SCREENING OF SYNTHESIZED COMPOUNDS FOR ACTIVITY 
AGAINST GRAM POSITIVE ORGANISMS 
 
Zone of inhibition of the sensitive compounds against 
Staphylococcus aureus NCIM 5021 
 
Concentration used  : 1000 mcg /disc and 500 mcg/disc 
Standard disc   : Ciprofloxacin 5 mcg /disc 
Solvent used   : N,N-Dimethyl formamide 
 
 
Chapter 6          
Spectral Studies 
 86
 
 
  
SCREENING OF SYNTHESIZED COMPOUNDS FOR ACTIVITY 
AGAINST GRAM POSITIVE ORGANISMS 
 
Zone of inhibition of the sensitive compounds against 
Basillus subtilis NCIM 2010 
 
Concentration used  : 1000 mcg/disc and 500 mcg/disc 
Standard disc   : Ciprofloxacin 5 mcg/disc 
Solvent used   : N,N-Dimethyl formamide 
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Table: 6 QUANTITATIVE SCREENING OF THE TEST COMPOUNDS 
FOR ANTIBACTERIAL ACTIVITY AGAINST GRAM NEGATIVE 
ORGANISMS 
 
Diameter of Zone of Inhibition in mm 
Proteus vulgaris 
NCIM 2027 
Pseudomoas aeruginosa 
NCIM 5029 
S. 
No. 
Compound 
Code* 
1000mcg/disc 500mcg/disc 1000mcg/disc 500mcg/disc
1 FCP1S  - 13mm - 
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2 *FCP3S - - - - 
3 FCP4S - - - - 
4 FCP5S - - - - 
5 DCP1S - - - - 
6 DCP2S - - - - 
7 *DCP3S - - - - 
8 *DCP4S - - - - 
9 *DCP5S - - - - 
10 DP1S - - - - 
11 *DP2S - - - - 
12 DP3S <11mm -  - 
13 DP4S - - - - 
14 DP5S - -- - - 
15 Blank (DMF) - - - - 
16 
Standard 
Ciprofloxacin  
(5 mcg/disc) 
38 23 
(-) indicates no zone of inhibition 
Zone diameter: 18 and above- Sensitive, 12-17-Moderately sensitive, <12- 
Resistant  
* Compounds were screened only at concentration of 500 mcg/ disc 
 
 
SCREENING OF SYNTHESIZED COMPOUNDS FOR ACTIVITY 
AGAINST GRAM NEGATIVE ORGANISMS 
 
Zone of inhibition of the sensitive compounds against 
Pseudomoas aeruginosa NCIM 5029 
 
Concentration used  : 1000 mcg/disc and 500 mcg/disc 
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Standard disc   : Ciprofloxacin 5 mcg/disc 
Solvent used   : N,N-Dimethyl formamide 
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DETERMINATION OF MINIMUM INHIBITORY CONCENTRATION 
 Compound with good activity were selected for the determination of 
minimum inhibitory concentration. Muller Hinton broth is used as the media 
for bacterial screening. 
 Preparation of inoculums 
 The inoculum for the experiment was prepared fresh in the media 
from preserved frozen slant culture. It was kept incubated at 37oC for 24 
hrs and used for the study after dilution to give 1: 10 or 1:100 dilutions. 
Standardization of inoculum 
 After overnight incubation, the test organism was diluted to 1:100. 
Standard drop of 0.01 ml was used for the determination of minimum 
inhibitory concentration. 
  
In Vitro determination of Minimum Inhibitory Concentration 
 It was carried out by two fold serial dilution technique. 
Procedure 
¾ Test tubes were numbered as 1-9 and 1 ml of Muller Hinton broth 
was added to each tubes. They were autoclaved at a pressure of 15 
psi at 121оC temperature not less than 15 mins. 
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¾ 1ml of the diluted stock solution (1000 mcg/disc) was added to the 
first test tube and serially transfer 1 ml upto the 8th test tube to 
obtain the quantities indicated. 
¾ From the 8th test tube, 1 ml was discarded. 
¾ The 9th test tube was used as the control. 
¾ Diluted broth culture of the test organism (0.01ml) was added to all 
the test tubes including the control with a standard micropipette. 
Mixed gently and incubated at 37оC for 16-18 hrs. 
¾ Readings were observed. 
¾ The above procedure was carried out in duplicate. 
¾ The MIC was interpreted as the highest dilution of the test 
compound, which showed clear fluid with no development of 
turbidity. 
Table: 7 
Tube number 1 2 3 4 5 6 7 8 Control 
Media (ml) 1 1 1 1 1 1 1 1 1 
Drug in serial 
dilution (ml) 1 1 1 1 1 1 1 1 - 
Discard (ml) - - - - - - - 1 - 
Culture Add 0.01 ml to each tube, Mix gently, kept in incubator for 24 hrs  
Chapter 6          
Spectral Studies 
 92
Concentration 
(mcg/ml) 1024 512 256 128 64 32 16 8 - 
 
Media used for bacterial screening: Muller Hinton broth  
 
IN VITRO MIC DETERMINATION OF COMPOUNDS AGAINST 
Staphylococcus aureus NCIM 5021 
 The in vitro MIC determination of FCP3S, DCP3S, DCP5S was 
carried out by two fold serial dilution technique against staphylococcus 
aureus NCIM 5021. The concentration range was fixed from 1024 to 8 
mcg/ml. The results were tabulated below 
Table: 8 
Concentration (mcg/ml) 
Compound 
code 
1024 512 256 128 64 32 16 8 
MIC 
values 
(mcg/ml) 
FCP3S - - - - + + + + 128 
DCP3S - - - - - + + + 64 
DCP5S - - - - - + + + 64 
Control - - - - - - - -  
Blank + + + + + + + +  
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 (+) indicates turbidity 
 (-)  indicates clear 
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IN VITRO MIC DETERMINATION OF COMPOUNDS AGAINST 
Bacillus subtilis NCIM 2010 
 The in vitro MIC determination of FCP3S, DCP3S, DP2S was carried 
out by two fold serial dilution technique against staphylococcus aureus 
NCIM 5021. The concentration range was fixed from 1024 to 8 mcg/ml. 
The results were tabulated below. 
Table: 9 
Concentration (mcg/ml) 
Compoud 
code 
1024 512 256 128 64 32 16 8 
MIC 
values 
(mcg/ml) 
FCP3S - - - - + + + + 128 
DCP3S - - - - - - - + 16 
DP2S - - - - - + + + 64 
Control - - - - - - - -  
Blank + + + + + + + +  
  
 (+) indicates turbidity 
 (-)  indicates clear 
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SCREENING FOR ANTIFUNGAL ACTIVITY 
MATERIALS AND METHODS: 
Media    : Sabouraud Dextrose Agar  
Ingredients    
 Mycological peptone :    10 gm 
 Dextrose   :    40 gm 
 Agar    :    15 gm 
 Final pH at 250C         :    5.4 ± 0.2 
 Water to make 1000 ml 
Preparation 
 65 gm of Sabouraud dextrose agar was suspended in 1000 ml of 
distilled water and boiled to dissolve the medium completely. 
Sterilization 
 15-30 ml of Sabouraud dextrose agar was transferred to comical 
flask and sealed. It was then autoclaved at a pressure of 15 psi (121oc) for 
not less than15 minutes. 
Organism used 
 Candida albicans NCIM 3100 and Aspergillus niger NCIM 545 were 
procured from National Chemical Laboratory, Pune and stored in the 
Pharmaceutical Biotechnology Laboratory, College of Pharmacy, SRIPMS, 
Coimbatore. 
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Working conditions 
 The entire work was done using horizontal laminar flow hood so as 
to provide aseptic conditions. Before commencement of the work air 
sampling was carried out using a sterile nutrient agar plate and exposing it 
to the environment inside the hood. After incubation it was checked for the 
growth of microorganism and absence of growth confirmed aseptic 
working conditions. 
Preparation of inoculum  
 The inoculum for the experiment was prepared fresh in Sabouraud 
Dextrose broth from preserved frozen slants. It was incubated at 25oC for 
24-48 hrs and used after standardization. 
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ANTIFUNGAL SCREENING 
 Sabouraud dextrose agar plates were prepared aseptically to get a 
thickness of 5-6 mm. The plates were allowed to solidify and inverted to 
prevent the condensate falling on the agar surface. The plates were dried 
at 25oC just before inoculation. 
 The organisms (Candida albicans NCIM 3100 and Aspergillus niger 
NCIM 545) were inoculated in the plates prepared earlier by dipping sterile 
swab in the inoculum, removing the excess of inoculum by pressing and 
rotating the swab firmly against the sides of the culture tube above the 
level of the liquid and finally streaking a swab all over the surface of the 
medium three times, rotating the plates through the angle of 60o after each 
application. Finally the swab was pressed round the edges of the agar 
surface. It was left to dry at room temperature with the lid closed. Sterile 
discs containing the test, standard and blank were placed in the petridish 
aseptically. 
 Plates were prepared in triplicate and they were incubated at 25oC 
for 24-48 hrs, after placing them in the refrigerator for one hour to facilitate 
uniform diffusion. Observations were made for the zone of inhibition 
around the discs and compared with that of Fluconazole, the standard. All 
the compounds were tested for antifungal activity. 
Drugs used : Schiff's bases of carboethoxy pyrans and 
cyano pyrans 
Standard used :  Fluconazole (10mcg/disc) 
Vehicle used :  N,N-Dimethyl formamide 
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Table: 10 QUANTITATIVE SCREENING OF THE TEST COMPOUNDS 
FOR ANTIFUNGAL ACTIVITY 
Diameter of Zone of Inhibition in mm 
Candida albicans 
NCIM 3100 
Aspergillus niger 
NCIM 545 
Sl. 
No. 
Compound 
Code* 
1000mcg/disc 500mcg/disc 1000mcg/disc 500mcgg/disc
1 FCP1S  - - - 
2 *FCP3S - - - - 
3 FCP4S - - - - 
4 FCP5S - - - - 
5 DCP1S - - - - 
6 DCP2S - - - - 
7 *DCP3S - - - - 
8 *DCP4S - - - - 
9 *DCP5S - - - - 
10 DP1S - - - - 
11 *DP2S - - - - 
12 DP3S - - - - 
13 DP4S - - - - 
14 DP5S - -- - - 
15 Blank (DMF) - - - - 
16 
Standard 
(Fluconazole 
10 mcg/disc 
26 28 
(-) indicates no zone of inhibition 
Zone diameter: 18 and above- Sensitive, 12-17-Moderately sensitive, <12- 
Resistant  
* Compounds were screened only at concentration of 500 mcg/ disc 
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RESULTS AND DISCUSSION 
SYNTHESIS 
 All the newly synthesized compounds were evaluated for their 
physical (Melting point and TLC) and spectral ( IR, PMR, Mass) data. 
 
ANTIBACTERIAL ACTIVITY 
 All the newly synthesized compounds were screened for their 
antibacterial activity against both gram negative and gram positive 
organisms by Agar diffusion method (Kirby-Bauer method).  
Gram positive organisms screened 
 Staphylococcus aureus NCIM 5021 
 Bacillus subtilis NCIM 2010 
Gram negative organisms screened 
 Pseudomonas aeruginosa NCIM 5029 
 Proteus vulgaris NCIM 2027  
 Concentrations of 1000 mcg/disc, 500 mcg/disc were used for the 
test compounds and results are compared with standard drug 
Ciprofloxacin at 10 mcg/disc concentration. Dimethyl formamide was used 
as the solvent. The results were interpreted as per Kirby-Bauer method 
(18 mm & above: Sensitive, 12-17 mm: Moderately sensitive, <12 mm: 
resistant). 
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Activity against Gram positive Organism 
 Organism: Staphylococcus aureus NCIM 5021 
¾ Among the newly synthesized compounds FCP1S, FCP4S, DCP1S,   
 DP1S, DP3S, were found to be sensitive at concentration of  1000 
 mcg/disc. 
¾ The compounds FCP3S, DCP3S, DCP5S were found to be sensitive 
at concentration of 500 mcg/disc. All the other compounds were 
moderately sensitive. 
¾ MIC values of the compounds FCP3S, DCP3S, DCP5S were 
 determined as follows, 
Compound Code MIC Value 
FCP3S 128 mcg/disc 
DCP3S 64 mcg/disc 
DCP5S 64 mcg/disc 
 
Organism: Bacillus subtilis NCIM 2010 
¾ Among the newly synthesized compounds FCP4S, DCP2S, DP1S, 
 DP3S,  DP4S, were found to be sensitive at concentration of 1000 
 mcg/disc. 
¾ The synthesized compounds FCP3S, DCP3S, DCP4S, DP2S were 
 found to be sensitive at concentration of 500 mcg/disc, and all the 
 other compounds were moderately sensitive. 
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¾ MIC values of the compounds FCP3S, DCP3S, DP2S were 
 determined as follows:- 
Compound Code MIC Value 
FCP3S 128 mcg/disc 
DCP3S 16 mcg/disc 
DP2S 64 mcg/disc 
 
Activity against Gram negative Organism 
¾ The compound FCP1S was found to be moderately sensitive 
against pseudomonas aeruginosa NCIM 5209. All the other 
compounds were inactive against pseudomonas aeruginosa NCIM 
5209 and proteus vulgaris NCIM 2027. 
ANTIFUNGAL ACTIVITY 
 All the synthesized compounds were screened for antifugal activity 
against Candida albicans NCIM 3100 and Aspergillus niger NCIM 545 by 
Agar diffusion method (Kirby-Bauer method) using Fluconazole (25 
mcg/disc) as standard and Dimethyl formamide as solvent. 
¾ All the newly synthesized compounds found to be inactive against 
Candida albicans NCIM 3100, Aspergillus niger NCIM 545. 
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SUMMARY AND CONCLUSION 
SUMMARY 
 In the present work 14 Schiff's bases of carboethoxy pyrans and 
cyano pyrans were synthesized in two schemes. 
SCHEME-I 
 This scheme involved the synthesis of 9 Schiff's bases of cyano 
pyrans. 
STEP-I 
 This step involved the formation of chalcones from aldehydes and 
ketones in the presence of a base. 
STEP-II 
 This step involved the formation of cyano pyrans from chalcones in 
the presence of pyridine, malononitrile. 
STEP-III  
 In this step, Schiff's bases prepared from cyano pyrans and 
aldehyde in dioxan. 
SCHEME-II 
 This scheme involved the synthesis of 5 Schiff's bases of 
carboethoxy pyrans. 
STEP-I 
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 This step involved the formation of chalcone from aldehyde and 
ketones in the presence of a base. 
 
STEP-II 
 This step involved the formation of carboethoxy pyran from 
chalcone in the presence of pyridine, ethylcyanoacetate. 
STEP-III  
 In this step, Schiff's base prepared from carboethoxy pyran and 
aldehyde in dioxan. 
SPECTRAL STUDIES 
 The structure of the synthesized compounds has been established 
on the basis of UV, IR, PMR and Mass spectral data. 
 
SCREENING FOR BIOLOGICAL ACTIVITY 
Activity against Gram positive Organism: 
Organism: Staphylococcus aureus 
¾ Among the newly synthesized compounds FCP1S, FCP4S, DCP1S, 
 DP1S, DP3S were found to be sensitive at concentration of 1000 
 mcg/disc. 
¾ The compounds FCP3S, DCP3S, DCP5S were found to be sensitive 
at concentration of 500 mcg/disc. All the other compounds were 
moderately sensitive. 
Chapter 6          
Spectral Studies 
 105
Organism: Bacillus subtilis 
¾ Among the newly synthesized compounds FCP4S DCP2S, DP1S, 
DP3S, DP4S, were found to be sensitive at 1000 mcg/disc. 
 
¾ The synthesized compounds FCP3S, DCP3S, DCP4S, DP2S were 
found to be sensitive at concentration of 500 mcg/disc. All the other 
compounds were moderately sensitive. 
Activity against Gram negative Organism 
¾ The compound FCP1S was found to be moderately sensitive 
against pseudomonas aeruginosa. All the other compounds were 
not active against Pseudomonas aeruginosa and proteus vulgaris.  
ANTIFUNGAL ACTIVITY 
¾ All the newly synthesized compounds were found to be inactive 
against Candida albicans, Aspergillus niger. 
CONCLUSION 
¾ All the newly synthesized compounds were found to be sensitive, 
moderately sensitive against gram positive organisms. 
¾ Among the newly synthesized compounds FCP1S, FCP4S, DCP1S, 
DP1S, DP3S were found to be sensitive at concentration of 1000 
mcg/disc against staphylococcus aureus. 
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¾ The compounds FCP3S, DCP3S, DCP5S were found to be sensitive 
at concentration of 500 mcg/disc against Staphylococcus aureus. 
All the other compounds were moderately sensitive. 
¾ Among the newly synthesized compounds FCP4S DCP2S, DP1S, 
DP3S, DP4S, were found to be sensitive at 1000 mcg/disc against 
Bacillus subtilis. 
 
¾ The synthesized compounds FCP3S, DCP3S, DCP4S, DP2S were 
found to be sensitive at concentration of 500 mcg/disc against 
Bacillus subtilis. All the other compounds were moderately 
sensitive. 
¾ The compound FCP1S were found to be moderately sensitive 
against pseudomonas aeruginosa. All the other compounds were 
not active against Pseudomonas aeruginosa and proteus vulgaris.  
¾ All the newly synthesized compounds were not active against 
Candida albicans, Aspergillus niger. 
  From the above observation, it was concluded that various 
derivatives of carboethoxy pyran and cyano pyran are one of the milestone 
in the research area. In the present work, all the compounds were active 
against gram positive bacteria. This work may encourage to do further 
studies on pyran moiety. 
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LIST OF NEWLY SYNTHESIZED COMPOUNDS 
 
 
Compound 
code 
Chemical name Structure 
FCP1S 
 
2-{[(E)-(4-
chlorophenyl)methylidene]amino}-
6-(4-nitrophenyl)- )-4-(furan-2-yl)-
4H-pyran-3-carbonitrile 
 
 
O N
CN
O2N
Cl
O
 
 
 
FCP3S 
 
2-{[(E)-(4-
chlorophenyl)methylidene]amino}-
6-(4-fluorophenyl)-4-(furan-2-yl)-
4H-pyran-3-carbonitrile 
O N
CN
F
Cl
O
 
 
 
FCP4S 
2-{[(E)-(4-
chlorophenyl)methylidene]amino}-
6-(4-methylphenyl)- )-4-(furan-2-
yl)-4H-pyran-3-carbonitrile 
 
 
O N
CN
H3C
Cl
O
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FCP5S 
2-{[(E)-(4-
chlorophenyl)methylidene]amino}-
6-(4-methoxyphenyl)- )-4-(furan-
2-yl)-4H-pyran-3-carbonitrile 
 
 
O N
CN
H3CO
Cl
O
 
 
DCP1S 
2-{[(E)-(4-
chlorophenyl)methylidene]amino}-
6-(4-nitrophenyl)-4-(4-dimethyl 
aminophenyl)- 4H-pyran-3-
carbonitrile O
CN
N
O2N
N
CH3CH3
Cl 
DCP2S 
2-{[(E)-(4-
chlorophenyl)methylidene]amino}-
6-(4-chlorophenyl)-4-(4-dimethyl 
aminophenyl)- 4H-pyran-3-
carbonitrile O
CN
N
Cl
N
CH3CH3
Cl 
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DCP3S 
2-{[(E)-(4-
chlorophenyl)methylidene]amino}-
6-(4-fluorophenyl)-4-(4-dimethyl 
aminophenyl)- 4H-pyran-3-
carbonitrile 
 
 
O
CN
N
F
N
CH3CH3
Cl 
DCP4S 
2-{[(E)-(4-
chlorophenyl)methylidene]amino}-
6-(4-methylphenyl)-4-(4-dimethyl 
aminophenyl)- 4H-pyran-3-
carbonitrile O
CN
N
H3C
N
CH3CH3
Cl 
DCP5S 
2-{[(E)-(4-
chlorophenyl)methylidene]amino}-
6-(4-methoxyphenyl)-4-(4-
dimethyl aminophenyl)- 4H-pyran-
3-carbonitrile O
CN
N
H3CO
N
CH3CH3
Cl
DP1S 
2-{[(E)-(4-
chlorophenyl)methylidene]amino}-
6-(4-nitrophenyl)-4-(4-dimethyl 
aminophenyl)- 4H-pyran-3-
carboxylate O N
Cl
N
CH3CH3
O2N
COOC2H5
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DP2S 
 
2-{[(E)-(4-
chlorophenyl)methylidene]amino}-
6-(4-chlorophenyl)-4-(4-dimethyl 
aminophenyl)- 4H-pyran-3-
carboxylate 
O N
Cl
N
CH3CH3
Cl
COOC2H5
 
DP3S 
2-{[(E)-(4-
chlorophenyl)methylidene]amino}-
6-(4-fluorophenyl)-4-(4-dimethyl 
aminophenyl)- 4H-pyran-3-
carboxylate O N
Cl
N
CH3CH3
F
COOC2H5
 
DP4S 
2-{[(E)-(4-
chlorophenyl)methylidene]amino}-
6-(4-methylphenyl)-4-(4-dimethyl 
aminophenyl)- 4H-pyran-3-
carboxylate O N
Cl
N
CH3CH3
H3C
COOC2H5
 
DP5S 
2-{[(E)-(4-
chlorophenyl)methylidene]amino}-
6-(4-methoxyphenyl)-4-(4-
dimethyl aminophenyl)- 4H-pyran-
3-carboxylate O N
Cl
N
CH3CH3
H3CO
COOC2H5
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